It’s All Connected: Understanding Cardio-Kidney-Metabolic Syndrome
In this foundational video, PA Viet Le provides an overview of CKM syndrome, a systemic disorder linking metabolic dysfunction, kidney disease, and cardiovascular outcomes. He explains how these conditions are interconnected, why early detection matters, and how the American Heart Association’s 2023 advisory defines CKM staging. The video offers a clinical roadmap to recognizing CKM across stages 0 through 4. It emphasizes the public health urgency of CKM, given the growing prevalence of obesity, diabetes, and disparities in care.
Key Takeaways:
- CKM syndrome is a systemic disorder leading to multiorgan dysfunction and a high rate of adverse CV outcomes.
- CKM is a progressive condition with biological, social, and environmental drivers.
- With earlier screening, we can treat patients with the intent to halt or reverse disease progression.
Speaker
Click on the photo below to learn more about the speaker.
References and Additional Resources:
Cardiovascular Kidney Metabolic Health: A Presidential Advisory From the AHA. Heart.org. Accessed July 28, 2025. https://professional.heart.org/en/science-news/cardiovascular-kidney-metabolic-health-a-presidential-advisory
Khan MS, Shahid I, Anker SD, et al. Albuminuria and heart failure: JACC state-of-the-art review. J Am Coll Cardiol. 2023;81(3):270-282. doi:10.1016/j.jacc.2022.10.028
Supported by
